INTRODUCTION
Cellular phenotype is determined by the specific set of gene products unique to a given cell. Since all cells in an organism bear the identical set of genes (with some exceptions such as the antibody-producing cells), the control of cellular phenotype is a manifestation of the control of expression of the genes in a particular cell. An understanding of the underlying mechanisms of gene control, including the molecules that participate in gene control, is of obvious importance to attaining a real understanding of the basis for cellular differentiation, early embryonic development, and oncogenesis, to name but a few examples.
The use of animal viruses has proved invaluable in the elucidation of these mechanisms. Viruses offer the advantage of simple gene systems that are easy to manipulate in the context of their normal control; they afford the opportunity to analyze high-copy genes by increasing the multiplicity of infection; and, probably most important, they provide a genetic basis for defining functions involved in the regulation of gene expression. In no other case have these advantages been better exemplified than in that of adenovirus. The study of adenovirus gene structure and gene regulation over the years has provided many of the underlying principles on which present day experiments are built. The definition that the start site of polymerase II transcription specified the messenger ribonucleic acid (mRNA)5' end (156) , the discovery of RNA splicing (6, 18) , the finding that RNA cleavage rather than transcription termination generated the mRNA 3' end (99) , and the development of systems for in vitro transcription (86, 143) that have allowed the isolation of transcription factors were all first realized in adenovirus systems. Since these initial findings, the study of adenovirus gene expression has rapidly progressed. The focus of this review is the regulation of expression of the early genes of the virus. For more general considerations, the reader is t Present address: Howard Hughes Medical Institute, Department of Microbiology and Immunology, Duke University Medical Center, Durham, NC 27710. referred to several recent reviews of the subject of adenovirus gene structure or virus replication in general (115, 128, 132) .
GENE ORGANIZATION
The structure and genome map locations of the early viral RNAs have been defined in a number of ways, including electron microscopy (17, 70) , S1 nuclease mapping (9) , in vitro translation of hybrid-selected RNA (81, 125) , and complementary deoxyribonucleic acid (DNA) cloning (105, 122) . Many of the details of this mapping have been reviewed previously (115, 132, 139, 140) and are summarized in Fig. 1 . Although function has been assigned to many of the products of the early RNA, there remain many species for which there is no known activity.
Although there are numerous reasons for defining the structure of a given gene, this information is crucial for allowing an understanding of the regulation of expression of the gene. As discussed in detail elsewhere (98) , the process of formation of a eucaryotic mRNA is complex, involving not only transcription but also a variety of RNA processing events before the mature mRNA is produced. Thus, if the steady-state concentration of a particular viral mRNA varies from one condition to another, it could be the result of an alteration of any one of the preceding events in mRNA biogenesis. This complexity is best illustrated by examining the organization of early adenovirus transcripts as depicted in Fig. 1 . The early viral transcripts map throughout the viral genome, encoded by both DNA strands, and are organized into six distinct transcription units (a transcription unit being defined as that section of a genome between a promoter and a terminator for RNA polymerase). The definition of these transcription units was accomplished by both ultraviolet mapping (8, 145) and nascent chain analysis (26 E2 product could result from control of transcription initiation, poly(A) site choice (E2A or E2B), or splicing choice.
TEMPORAL EXPRESSION OF EARLY GENES
The pattern of early viral gene expression has been determined by a variety of assays, although the initial descriptions measured protein synthesis. Even from these early studies, it was clear that there was control of early gene expression since the kinetics of synthesis of various early proteins differed (95) . A further analysis of early gene expression indicated that most of the control of appearance and decline of early gene products was the result of transcriptional regulation (100). The transcription rates from each of the early regions varied with respect to both the onset of activity and the maintenance of transcription rates. In particular, the ElA and E4 transcription units are activated very early in the infection, followed by E3, E1B, and finally E2. Transcription of ElA and ElB continues well into the late phase of infection, whereas transcription of E4 is rapidly shut off and transcription of E2 and E3 slowly declines. These kinetics are generally coincident with the appearance of the gene products during the course of an infection.
Although there is no evidence for post-transcriptional control of early gene expression, there is clear evidence in three cases for such control when early regions are expressed both early and late in infection. First, a 9S ElA mRNA is produced late in infection but not early, whereas the 13S and 12S ElA RNAs are produced both early and late (121) . All three RNAs derive from a common precursor with a single poly(A) site, suggesting that there is a change in splicing control (105) . Second, the E1B 20S mRNA is the predominant species early in infection, whereas late in infection the 14S EiB mRNA becomes the major RNA. In this instance, it appears that differential stabilities of the RNAs are responsible for the change in ratio (144) . Finally, the proximal half of the major late transcription is expressed both early and late (3, 17, 102, 117) . The major product during early infection is a single Li mRNA (3, 102) , whereas the same region expressed late in infection produces at least three LI mRNAs, five L2 mRNAs, and three L3 mRNAs (115) . The families of Li, L2, and L3 RNAs are determined by distinct poly(A) sites, and the individual species within a family are defined by a distinct splicing event (99) . Therefore, changes in both poly(A) site choice and splicing choice appear to be responsible for the observed changes between early and late infection. In the case of Li RNA production, pulse-labeling studies demonstrated that a change in splicing is almost certainly responsible for the shift in RNA production (102) .
The basis for these changes remains obscure. (85, 116) , no information is yet available concerning the basis for alternative choices in RNA processing pathways.
The tight control of early gene expression directed by transcription rate changes is possible since the early mRNAs decay rapidly, with half-lives of no more than 20 min (146) .
The product of the E2A region, the 72-kilodalton (kDa) DNA binding protein, appears to mediate the rapid decay of early mRNA (4) . In the absence of a functional E2A gene product, there is an overproduction of each viral mRNA (14) . Direct assays of turnover rates demonstrated that the stability of the early RNAs increased three to fivefold when produced in a ts125 infection, a mutant encoding a thermolabile 72-kDa protein (38, 135 72 -kDa protein-directed turnover is a regulatory event other than ensuring that transcriptional control will result in rapid changes in the mRNA population due to the short half-life of the RNA.
TRANSCRIPTION CONTROL
As suggested in the preceding section, the activation mechanisms of the various early transcription units are not identical, suggesting an underlying control of this process.
Indeed, through the analysis of adenovirus mutants defective in the ElA function (47, 61) , it was established that production of the early RNAs depended on the ElA gene (7, 62) . Soon thereafter it was shown that the positive control of ElA was largely transcriptional (96) , although there appeared to be post-transcriptional effects 'as well (66) . Although it has not been demonstrated in the context of control of viral genes, ElA also appears to exert negative effects on transcription as well as the positive control (11, 138) . Possibly this is for the purpose of autoregulation in the context of a productive infection (120) , but it may also be involved in the shutoff of E2 transcription (43) . Finally, in addition to the regulation of transcription by ElA, there is negative transcription control mediated by the E2A product. As mentioned previously, transcription of the E4 region quickly reaches a peak level and then declines. It was initially observed that this decline required protein synthesis, suggesting an active repression, possibly by a viral protein (100). Indeed, it was found that the product of the E2A gene, the 72-kDa DNA-binding protein, was required for this shutoff (101) . Later experiments demonstrated a specific repression of E4 transcription in vitro by the purified 72-kDa protein (44) , although the mechanistic basis for the repression is yet to be understood since there is no evidence for sequence-specific binding by the 72-kDa protein (29) .
ACTIVATION OF TRANSCRIPTION BY ElA
Since the initial discovery of the regulatory role of ElA, a great deal of effort has been devoted to understanding the mechanism for ElA-mediated control. Several features contribute to the attractiveness of this particular system of gene control. First, it represents a system of coordinate gene control whereby six viral promoters (ElA, E1B, E2, E3, E4, and ML) as well as-several cellular promoters (details discussed below) are subject to activation by a single regulatory gene product. Second, the system is sufficiently simple that one may hope to understand how an entire regulatory circuit operates. Finally, it has become clear from a number of studies that ElA mediates transcription control through cellular components, and thus an understanding of the activation of these viral genes may lead to an understanding of transcription control within the cell.
The "ElA gene" is actually a set of three transcripts that encode three separate proteins (Fig. 2) . As indicated above, the 9S mRNA is only produced in cells infected late (121) , and therefore the product of this RNA is not involved in transcription control. The 13S and 12S RNAs, which are expressed early, encode proteins of 289 and 243 amino acids, respectively, based on the complementary DNA and genomic DNA sequence (105, 136) . These two proteins are identical in sequence except for 46 additional amino acids near the middle of the 13S product. Studies of various ElA mutants have demonstrated that the 289-amino acid 13S RNA product is the primary activator of early viral transcription (39, 90, 92, 108) ,-although it does appear that the 12S product can effect an inefficient stimulation of the same genes stimulated by the 13S product (28, 18, 147 (28) . although one report has suggested that the ElA protein could interact with DNA in the presence of cell extracts (71) .
Analysis of early gene expression in d1312 infections has provided evidence for a cellular regulatory activity similar in nature to ElA. Imperiale et al. (58) found that certain cell lines could partially complement the ElA defect in d1312 for early transcription whereas in other cells there was an absolute requirement for the viral ElA. Possibly the most informative example was the mouse F9 teratocarcinoma cell line, a tumor cell line with properties characteristic of the undifferentiated early embryo (87, 126) . The cells in culture are rapidly growing undifferentiated cells that form tumors when injected into animals. In the presence of retinoic acid and cyclic adenosine 5'-monophosphate, the cells differentiate and acquire properties similar to that of primitive endoderm and lose their proliferative and oncogenic capacity (127) . It was found that F9 cells could complement an ElA mutant for early gene expression whereas the differentiated F9 cells could not (58) . Thus, there appeared to be a cellular activity, similar in function to that of the viral ElA gene, which was controlled during differentiation.
The possibility that ElA control involved cellular components and factors was consistent with the previous finding that the genes subject to ElA control were not limited to the set of early genes on the viral chromosome. Initially it was found that adenovirus infection induced the synthesis of a 70-kDa cellular protein that turned out to be the major heat shock protein (97) . This induction required ElA and, with the use of a complementary DNA, was shown to be transcriptional (65) . Furthermore, the kinetics of activation of hsp70 transcription were identical to that of the early viral genes. Subsequently, it was shown that the P-tubulin gene was activated by ElA in a lytic infection (123) . More recently, several other genes have been found to be induced by ElA. An additional heat shock gene, hsp89, is activated by ElA during lytic infection (118) . Furthermore, the synthesis of a cellular protein termed PCNA (proliferating cell nuclear antigen), also known as cyclin, is stimulated in an adenovirus infection, dependent on the ElA gene, as is the gene encoding thymidylate synthetase (155) . Although it is not yet clear that the increase in PCNA synthesis is due to an increase in transcription, the induction shares an interesting property with that of hsp70. In contrast to the activation of the early viral genes, the induction of hsp70 (118) and PCNA (155) can be mediated by the 12S ElA gene product as well as the 13S product. Interestingly, recent data have shown that PCNA is a factor required for the in vitro elongation of simian virus 40 (SV40) DNA synthesis in cell-free extracts (106) . Perhaps the ElA-mediated induction of PCNA is part of the process of the induction of DNA synthesis of ElA, a possibility consistent with the observation that the E1A-regulated hsp70 gene is also cell cycle regulated (64, 148) . Finally, in line with the role of ElA in induction of cellular proliferation is the observation that several cell cycleregulated genes appear to be induced by adenovirus infection, although it is not clear that this is a function of ElA (83) .
In addition to the activation of these chromosomally located cellular genes, it was found that a multitude of plasmid-borne genes could be activated by ElA in transfection experiments. Transfection assays demonstrated that the human P-globin promoter was stimulated by ElA as well as by the pseudorabies virus immediate early gene (42) , as was the early SV40 promoter in these experiments, but the a-globin promoter was only weakly stimulated, if at all.
Various other experiments have now shown a number of promoters to be responsive to ElA or herpesvirus regulatory genes, either in transient transfection assays or when the target gene is incorporated into either the adenovirus or the cellular chromosome (23, 35, 82, 129) . Thus, the effects of ElA in stimulating transcription appeared to be widespread and certainly not restricted to the set of viral genes that are the normal targets of activation. Furthermore, this phenomenon appears to be typical among a variety of viral trans activators that have in common the property that they encode nucleus-localized proteins which are oncogenic (for review, see reference 68).
Finally, it has been shown that the genes subject to ElA activation are not limited to those transcribed by RNA polymerase II since ElA appears to influence the expression of genes transcribed by RNA polymerase III. Extracts prepared from adenovirus-infected cells were found to be more active in the transcription of the VA gene than extracts from uninfected cells (34, 53 (36) . However, the induced transcription from this deleted promoter is greatly reduced. Likewise, a linker-scanning mutation in the E1B TATA sequence appears to have little effect on basal transcription but does impair induced transcription (150) . From these studies, one must conclude that in some cases (E4 and E1B) induction may involve a specific factor not used for basal transcription whereas in other cases the same factor(s) necessary for uninduced is also required for induced transcription.
Based on long-term infections with an ElA mutant, Gaynor and Berk (33) Additional experiments have established a firm relationship between the level of E2F in cell extracts and the transcription of the E2 promoter inside cells. For instance, the kinetics of appearance of E2F during an early infection coincide with the activation of E2 transcription (R. Reichel, I. Kovesdi, and J. Nevins, Proc. Natl. Acad. Sci. USA, in press). In addition, the activation of E2F requires the 13S product of the ElA gene, also a requirement for induction of E2 transcription. As described above, previous work has demonstrated the existence of a cellular ElA-like activity based on the ability to partially complement the transcriptional inducing defect of an ElA mutant (58) . Particularly informative was an analysis of the mouse F9 teratocarcinoma cell line since undifferentiated F9 cells exhibited an ElA-like activity which disappeared upon induction of differentiation by retinoic acid and cyclic adenosine 5'-monophosphate. Examination of extracts of F9 cells and differentiated F9 cells revealed a coregulation of E2F (107). There was a high level of E2F in F9 extracts, whereas the extracts of differentiated cells were devoid of the factor. However, if the viral ElA gene was introduced into the differentiated cells by means of a viral infection, the E2F factor reappeared. Thus, from a number of different lines of study, there exists a close correlation between the level of E2F and the presence of an ElA activity, either cellular or viral.
In addition to these correlations, there is direct evidence for a role of E2F in stimulating transcription. A DNA fragment containing a single E2F-binding site could confer increased transcriptional activity to the mouse P-globin promoter when inserted just upstream of the promoter (74) . This increase in transcription required the ElA protein, consistent with the fact that ElA increases the level of E2F. Also, that the binding of E2F was actually important was established by first treating the plasmid with HhaI methylase prior to transfection. The E2F-binding site (TT TCGCGC) is a substrate for HhaI methylase and, as a result of the methylation, binding of E2F is inhibited. Methylation also inhibits the ability of ElA to stimulate the ,B-globin fusion, demonstrating that ElA indeed stimulates via the E2F factor. It therefore appears certain that the E1A-mediated control of E2F is responsible for the stimulation of E2 transcription.
Other experiments have defined the relative role of E2F in E2 transcription. There are two binding sites for E2F within the E2 promoter (Fig. 3 (10, 73, 119, 151a) , are shown below. Also shown is the position of a block to exonuclease III digestion observed in vivo which presumably reflects a promoter-bound complex (72).
-80 are important for promoter activity (59, 94) , suggesting that at least one other factor might interact with the promoter. Indeed, gel shift assays detected a factor binding to these sequences (119) . Furthermore, direct footprint analysis with crude nuclear extracts demonstrated that both factors, E2F and the upstream factor, could interact simultaneously (151a). However, unlike E2F, the level of the upstream factor does not fluctuate with respect to ElA (119, iSla) . Therefore, both factors appear to be required for full promoter activity but E2F appears to be the limiting component. This finding is of interest when the analysis of in vivo protein-DNA interaction is considered. In the absence of ElA function, the E2 promoter was void of any stable complex (72 (46, 151) . Possibly, the purification of the factor, the production of an antibody, and the subsequent analysis of the protein will lead to an understanding of the basis of the Coordinate Control of Transcription In addition to the E2 promoter, the E1B, E3, E4, and ML promoters are also stimulated by ElA. Furthermore, ElA transcription is reduced three to fourfold in the absence of a functional ElA protein, indicating that there is stimulation of the ElA promoter as well (96) . Finally (48, 49) , indicating that the E2F factor may be critical for stimulation of both ElA and E2 genes. However, due to the lack of binding to the other promoters, this factor cannot be involved in the transcription of any of the other inducible genes. One must conclude that ElA control involves multiple promoter-specific factors.
If the E2F factor is not involved in stimulation of the other inducible promoters, what are the critical factors and what is the basis for coordinate control? Various studies have identified proteins that interact with the E1B promoter (150), the ML promoter (15, 89, 112) , the E4 promoter (82) , and the hsp70 promoter (93, 149) . Certainly, the best studied of these is the factor which interacts with the upstream regulatory site of the ML promoter and which has been purified to near homogeneity and shown to stimulate transcription in vitro (16) . However, there is no evidence to suggest that any of these proteins are involved in ElA stimulation of the respective promoters. They undoubtedly are essential for transcription but likely are not regulatory. Although there is as yet no direct evidence, several lines of study have implicated a TATA binding factor in ElA-mediated stimulation of transcription of certain promoters. The initial assays of ElA induction of the ,B-globin promoter demonstrated that only a TATA element was necessary for ElA stimulation in transfection assays and that a point mutation in the TATA sequence abolished the response to ElA (42) . More recently, Berk and colleagues, utilizing promoter mutations engineered into adenoviruses, have demonstrated that sequences upstream of the adenovirus E1B TATA could be deleted and yet inducibility by ElA was retained whereas a linkerscanning mutation directed at the TATA element eliminated ElA inducibility without affecting the basal level of promoter activity (150) . Thus, the promoter appeared to still function but was not responsive to ElA. Interestingly, the same may be true for the hsp70 promoter with respect to ElA induction. It appears from an analysis of a series of deletion mutants as well as internal substitution mutants that the critical element for ElA control is the TATA sequence (Simon et Although not involving ElA but rather the pseudorabies virus immediate early gene, a biochemical approach has come to the same general conclusion. Extracts prepared from cells infected with pseudorabies virus could stimulate transcription in vitro when mixed with a HeLa nuclear extract (1) . The stimulation only required the TATA element. Furthermore, recent data suggest that the stimulation is dependent on the pseudorabies virus immediate early protein and is mediated through the TFIID transcription factor (S. Abmayr and R. Roeder, manuscript in preparation), the factor that recognizes the TATA element (103, 112) . In addition, since the activation can occur in vitro, it would appear not to involve the synthesis of additional TFIID molecules (Abmayr and Roeder, in preparation). Finally, assays of an extensive set of thymidine kinase promoter mutations have suggested that the TATA sequence is the more important element for trans activation by the herpesvirus immediate early gene ICP4 (20) . Although these studies do not involve ElA, given the similarities in action of the two regulatory proteins it seems likely that similar mechanisms will apply to both.
In addition to the stimulation of polymerase II transcription, ElA also stimulates polymerase III transcription (5, 34, 53) . Analysis of extracts indicated that the induction of transcription from promoters utilizing polymerase III may involve the TFIIIC factor (53, 152) , the factor which recognizes the internal promoter element of class III genes (31, 75, 114) . From recent experiments, it appears that this may involve a modification of a preexisting TFIIIC that increases the stability of its interaction with the promoter (W. Hoeffler and R. Roeder, manuscript in preparation).
Based on all of these recent data, it would appear that ElA can affect the activity of at least three distinct DNA-binding proteins (E2F, TFIID, and TFIIIC) and by so doing cause a stimulation of transcription. One must then ask what these apparently unrelated protein factors share in common to allow for coordinate control by ElA. Possibly important is the observation that at least in two cases, if not all three, the induction likely involves a post-translational modification or alteration. Given this, we might speculate that, although these proteins must recognize different DNA sequences, they may share a common domain that is the site of action of ElA. The E2F, TFIID, and TFIIIC factors may all possess a common domain which is recognized by ElA (Fig. 4) In contrast to the activation of viral transcription, the 12S product appears to be as effective as the 13S product in the repression of transcription (11, 92, 138) . Indeed, sitedirected mutagenesis of the ElA gene has defined the second conserved domain (Fig. 2) as critical for the repression activity (82) , whereas region three of ElA appears to be critical for the activation of early viral transcription.
A series of observations from the mouse F9 teratocarcinoma system has led to speculation that negative control by a cellular ElA activity is important in the differentiation process. As detailed before, F9 cells contain an ElA-like activity which disappears upon differentiation (58) . It (58) and, of most significance, the presence of a cellular transcription factor (E2F) known to be regulated by ElA (107) .
However, the behavior of certain ElA mutants weighs against the above arguments for a role of positive transcription control in oncogenesis. ElA mutations localized to the 13S specific domain (domain III) or ElA genes expressing only the 12S product no longer trans activate with high efficiency but still transform (82, 90, 92) . Furthermore, mutations in domain II that have no apparent effect on transcription activation have been found to be transformation negative (82) . The former result suggests that transcription activation is not important for transformation, and the latter result clearly demonstrates that an ElA function other than transcription activation must be involved. Indeed, a good candidate function is transcription repression since these two properties, repression and transformation, appear to be tightly linked genetically. Furthermore, the case made for transcription activation in the F9 system can also apply to ElA-mediated transcription repression (40, 51) .
However, is the positive control of transcription by ElA clearly ruled out of a role in oncogenesis? For several reasons, the answer is no. First, the genetic analysis has the caveat that the mutants which affect the activation function but still transform do still possess a limited ability to trans activate viral gene expression. For instance, several studies have shown that the 12S ElA product can still activate viral transcription, although much less efficiently than the 13S product (28, 78, 147) . What is not known is the relative requirement for activation during oncogenesis (if any) as compared with the activation in a lytic infection. Clearly, it could be much less, and if so the limited capacity of the 12S produced might be sufficient. Furthermore, it has now been shown in several cases that the 12S product can activate certain cellular genes with an efficiency nearly equal to that of the 13S product (118, 155) .
The results of analyses of mutations in domain II have clearly shown that a function other than trans activation is important for transformation. It is thus tempting to speculate that both transcriptional activation and repression of key cellular genes are important for oncogenesis. The difficulty is that in either case this is only a correlation and will remain so until a cellular gene activated or repressed by ElA is shown to be essential for the transformed phenotype. Only then can it be said that either of these processes is important to the process. Such an experiment may be feasible for genes repressed by ElA since, once identified, it would be possible to reintroduce the gene in question into the transformed cell to determine if the phenotype was reversed. In contrast, to prove that a positively regulated gene is critical to the transformed phenotype may be very difficult since it would require a mechanism to turn off the activated gene. An approach with antisense constructs is possible, although by no means is it straightforward.
SUMMARY AND PERSPECTIVES The study of early adenovirus gene control has now advanced to a detailed understanding of many of the underlying mechanisms. More is known of the processes regulating the expression of this set of genes than for most other viral systems. In part, this is due to the relative ease of manipulation of the system. However, the major driving force behind these advances has undoubtedly been the relevance of this system of gene control to analogous cellular events. The study of adenovirus gene expression and the regulation of the early adenovirus genes has provided many of the fundamental details in our understanding of eucaryotic gene expression including the identification and isolation of cellular proteins involved in gene control. In this sense, adenovirus does not appear to represent a peculiar or unique situation but rather is an active participant in ongoing cellular events.
The future of this work is bright. Almost certainly, the details of ElA-mediated gene control, including the isolation of the proteins that participate and the manner in which ElA effects the regulation, will be unravelled in the coming few years. Less certain is the elucidation of the role of this system of gene control in the physiology of the cell, with respect to both oncogenesis and normal cellular growth control. Given the importance of such an understanding, there is little doubt that the attainment of these goals will not suffer from a lack of effort and one can therefore anticipate rapid strides in this direction.
